Rock Creek Pharmaceuticals Announces Interim Amendments to Convertible Notes and Update on Financing Options

Published on January 6, 2025

science focused investment advisory organization, on a best efforts basis, to assist in providing additional potential financing options

Continue reading on website
Other news

Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program

January 6, 2025
but not limited to, failure to obtain sufficient capital resources to fund our development program and operations, results of clinical

France's Ex-president Sarkozy On Trial Over Alleged Kadhafi Pact

January 6, 2025
office, goes on trial Monday charged with accepting illegal campaign financing in an alleged pact with the late Libyan dictator Moamer